Literature DB >> 3897061

Ecology of Candida albicans gut colonization: inhibition of Candida adhesion, colonization, and dissemination from the gastrointestinal tract by bacterial antagonism.

M J Kennedy, P A Volz.   

Abstract

Antibiotic-treated and untreated Syrian hamsters were inoculated intragastrically with Candida albicans to determine whether C. albicans could opportunistically colonize the gastrointestinal tract and disseminate to visceral organs. Antibiotic treatment decreased the total population levels of the indigenous bacterial flora and predisposed hamsters to gastrointestinal overgrowth and subsequent systemic dissemination by C. albicans in 86% of the animals. Both control hamsters not given antibiotics and antibiotic-treated animals reconventionalized with an indigenous microflora showed significantly lower gut populations of C. albicans, and C. albicans organisms were cultured from the visceral organs of 0 and 10% of the animals, respectively. Conversely, non-antibiotic-treated hamsters inoculated repeatedly with C. albicans had high numbers of C. albicans in the gut, and viable C. albicans was recovered from the visceral organs of 53% of the animals. Examination of the mucosal surfaces from test and control animals indicated further that animals which contained a complex indigenous microflora had significantly lower numbers of C. albicans associated with their gut walls than did antibiotic-treated animals. The ability of C. albicans to associate with intestinal mucosal surfaces also was tested by an in vitro adhesion assay. The results indicate that the indigenous microflora reduced the mucosal association of C. albicans by forming a dense layer of bacteria in the mucus gel, out-competing yeast cells for adhesion sites, and producing inhibitor substances (possibly volatile fatty acids, secondary bile acids, or both) that reduced C. albicans adhesion. It is suggested, therefore, that the indigenous intestinal microflora suppresses C. albicans colonization and dissemination from the gut by inhibiting Candida-mucosal association and reducing C. albicans population levels in the gut.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3897061      PMCID: PMC261235          DOI: 10.1128/iai.49.3.654-663.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  59 in total

1.  Inhibition of Candida albicans by Escherichia coli in vitro and in the germfree mouse.

Authors:  R P Hummel; E J Oestreicher; M P Maley; B G Macmillan
Journal:  J Surg Res       Date:  1973-07       Impact factor: 2.192

2.  Relationship between cecal population levels of indigenous bacteria and translocation to the mesenteric lymph nodes.

Authors:  E K Steffen; R D Berg
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

3.  Colonization resistance of the digestive tract and the spread of bacteria to the lymphatic organs in mice.

Authors:  D van der Waaij; J M Berghuis-de Vries
Journal:  J Hyg (Lond)       Date:  1972-06

4.  Antagonistic effects of Bacillus natto and Streptococcus faecalis on growth of Candida albicans.

Authors:  K Ozawa; K Yagu-Uchi; K Yamanaka; Y Yamashita; K Ueba; T Miwatani
Journal:  Microbiol Immunol       Date:  1979       Impact factor: 1.955

5.  Colonization of gnotobiotic mice by Roseburia cecicola, a motile, obligately anaerobic bacterium from murine ceca.

Authors:  T B Stanton; D C Savage
Journal:  Appl Environ Microbiol       Date:  1983-05       Impact factor: 4.792

6.  Growth and virulence of Candida albicans after oral inoculation in the chick with a monoflora of either Escherichia coli or Streptococcus faecalis.

Authors:  E Balish; A W Phillips
Journal:  J Bacteriol       Date:  1966-05       Impact factor: 3.490

7.  Survival and implantation of Escherichia coli in the intestinal tract.

Authors:  R Freter; H Brickner; J Fekete; M M Vickerman; K E Carey
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

8.  Continuous-flow cultures as in vitro models of the ecology of large intestinal flora.

Authors:  R Freter; E Stauffer; D Cleven; L V Holdeman; W E Moore
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

9.  Adherence of Candida albicans to human vaginal and buccal epithelial cells.

Authors:  J D Sobel; P G Myers; D Kaye; M E Levison
Journal:  J Infect Dis       Date:  1981-01       Impact factor: 5.226

10.  Efficiency of various intestinal bacteria in assuming normal functions of enteric flora after association with germ-free mice.

Authors:  S A Syed; G D Abrams; R Freter
Journal:  Infect Immun       Date:  1970-10       Impact factor: 3.441

View more
  73 in total

1.  Candida albicans and bacterial microbiota interactions in the cecum during recolonization following broad-spectrum antibiotic therapy.

Authors:  Katie L Mason; John R Erb Downward; Kelly D Mason; Nicole R Falkowski; Kathryn A Eaton; John Y Kao; Vincent B Young; Gary B Huffnagle
Journal:  Infect Immun       Date:  2012-07-09       Impact factor: 3.441

Review 2.  Immune defence against Candida fungal infections.

Authors:  Mihai G Netea; Leo A B Joosten; Jos W M van der Meer; Bart-Jan Kullberg; Frank L van de Veerdonk
Journal:  Nat Rev Immunol       Date:  2015-09-21       Impact factor: 53.106

Review 3.  Candida albicans Biofilms and Human Disease.

Authors:  Clarissa J Nobile; Alexander D Johnson
Journal:  Annu Rev Microbiol       Date:  2015       Impact factor: 15.500

4.  Gastrointestinal candidiasis in a murine model of severe combined immunodeficiency syndrome.

Authors:  R Narayanan; W A Joyce; R A Greenfield
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

5.  Biotherapeutic effects of probiotic bacteria on candidiasis in immunodeficient mice.

Authors:  R D Wagner; C Pierson; T Warner; M Dohnalek; J Farmer; L Roberts; M Hilty; E Balish
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

6.  Decontaminating efficacy of ciprofloxacin in an animal model.

Authors:  M L van Ogtrop; H Mattie; H F Guiot; R van Furth
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-10       Impact factor: 3.267

Review 7.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

8.  Biofilm-forming ability of Candida albicans is unlikely to contribute to high levels of oral yeast carriage in cases of human immunodeficiency virus infection.

Authors:  Y Jin; H K Yip; Y H Samaranayake; J Y Yau; L P Samaranayake
Journal:  J Clin Microbiol       Date:  2003-07       Impact factor: 5.948

9.  An Opaque Cell-Specific Expression Program of Secreted Proteases and Transporters Allows Cell-Type Cooperation in Candida albicans.

Authors:  Matthew B Lohse; Lucas R Brenes; Naomi Ziv; Michael B Winter; Charles S Craik; Alexander D Johnson
Journal:  Genetics       Date:  2020-08-24       Impact factor: 4.562

10.  Candida carriage in the alimentary tract of liver transplant candidates.

Authors:  S Kusne; D Tobin; A W Pasculle; D H Van Thiel; M Ho; T E Starzl
Journal:  Transplantation       Date:  1994-02       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.